
Ulf J. Johansson, Chairman, and fellow members of the Board of Novo A/S preside over the NASDAQ Opening Bell.
About Novo A/S [NVO]:
Novo A/S is the holding and investment company of the Danish Novo Group, wholly owned by the Novo Nordisk Foundation. Novo A/S was established in 1999 to manage the assets of the Foundation and actively make investments on behalf of the Foundation.Novo A/S is a major force within venture capital investing in the life sciences area, operates globally and has venture partners located in both Copenhagen, London and San Francisco. With an evergreen structure, Novo A/S annually invests approximately US$100 million in venture capital into private life sciences companies, and thus acts at a pace comparable to a traditional US$400 million fund. Over time Novo A/S has invested in more than 50 portfolio companies, of which the majority are located in North America
In total Novo A/S has more than US$12 billion under management, which includes significant shareholdings in the independently operating and publicly listed companies Novo Nordisk A/S and Novozymes A/S. For information visit www.novo.dk.